Elanco Animal Health (ELAN) Fundamental Analysis: Revenue, Earnings & Valuation

1.41 / 10

Underperform

Fundamental rating is Underperform with a low 1.4/10 score. Inventory and fixed‑asset turnover look decent, yet income‑tax ratio and accounts‑receivable turnover are poor, leading analysts to advise a prudent stance.

Analysis Checks(5/10)

Revenue-MV

Value0.03

Score2/3

Weight50.24%

1M Return6.87%

Total operating revenue (YoY growth rate %)

Value6.22

Score1/3

Weight-7.22%

1M Return-1.40%

Inventory turnover ratio

Value1.28

Score2/3

Weight-3.73%

1M Return-0.66%

Accounts receivable turnover ratio

Value5.62

Score1/3

Weight-8.38%

1M Return-1.57%

PB-ROE

Value-0.22

Score1/3

Weight31.42%

1M Return5.22%

Income tax / Total profit (%)

Value-3.57

Score1/3

Weight-3.05%

1M Return-0.59%

Fixed assets turnover ratio

Value3.93

Score2/3

Weight-5.31%

1M Return-1.01%

Interest coverage ratio (EBIT / Interest expense) (%)

Value34.91

Score2/3

Weight-3.76%

1M Return-0.73%

Cost of sales ratio (%)

Value45.01

Score2/3

Weight-3.69%

1M Return-0.74%

Asset-MV

Value-0.55

Score1/3

Weight53.49%

1M Return7.28%

Is ELAN fundamentally strong?

ELAN scores 1.41/10 on fundamentals and holds a Premium valuation at present. Backed by its -3.67% ROE, -4.92% net margin, -54.65 P/E ratio, 1.94 P/B ratio, and -169.12% earnings growth, these metrics solidify its Underperform investment rating.